Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2022
  • Volume: 15
  • Issue: 11

Bridging between disorder, prevalence, clinical manifestation and therapeutic management of muscular dystrophy

  • Author:
  • Nigama Chandra Sattenapalli1, Ranjit Prasad Swain2,*, Siva Naga Koteswara Rao Gudhanti1
  • Total Page Count: 7
  • Page Number: 4901 to 4907

1Department of Pharmaceutics, K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Andhra PradeshIndia

2Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India

*Corresponding Author E-mail: ranjit.prasad797@gmail.com

Online published on 3 March, 2023.

Abstract

The main purpose of the present review is to compile the recent information with special focus on different aspects of muscular dystrophy. Muscular dystrophies are the group of genetic disorders that causes progressive muscle weakness and degeneration of skeletal muscles, restricts their movement and functions, and is irreversible. There is no clear picture and statistics on muscular dystrophy effected individuals especially in India. This article specifies and acknowledges the muscular dystrophy facts and particulars all over the world especially focusing the story in India. The study is based on statistics taken from several reports gathered by different organizations in India, as well as, from other data sources published. In this regard, this present review highlighted the areas of epidemiology, present scenario of prevalence, types of muscular dystrophy specially focused on genetic involment, identification of clinical symptoms, clinical diagnosis specially focused in India, care, management and treatment of this disorder.

Keywords

Muscular dystrophy, Genetic disorder, Prevalence, Clinical manifestation